Greater Cannabis Company (GCAN) Enterprise Value (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Enterprise Value of -$1439.0 in Q1 2026, down 76.56% quarter-over-quarter from -$815.0 in Q4 2025, and up 96.89% on a YoY basis from -$730.88 in Q1 2025.
Greater Cannabis Company (GCAN) Enterprise Value (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Enterprise Value history runs 10 years deep, the most recent figure standing at -$1439.0 for Q1 2026.
- In Q1 2026, Enterprise Value rose 96.89% year-over-year to -$1439.0; the TTM figure through Mar 2026 stood at -$1439.0 (up 96.89% YoY), while the FY2025 annual figure was -$815.0, up 98.58% from the prior year.
- Enterprise Value was -$1439.0 for Q1 2026 at Greater Cannabis Company, down from -$815.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$815.0 in Q4 2025 to a low of -$289094.0 in Q3 2022.
- Historically, Enterprise Value has averaged -$113720.4 across 5 years, with a median of -$71299.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value advanced 28.47% in 2022, then surged 98.58% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$270030.0 in 2022, then soared by 38.21% to -$166859.0 in 2023, then soared by 65.62% to -$57368.0 in 2024, then soared by 98.58% to -$815.0 in 2025, then tumbled by 76.56% to -$1439.0 in 2026.
- The last three Enterprise Value figures came in at -$1439.0 (Q1 2026), -$815.0 (Q4 2025), and -$21355.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | Greater Cannabis Company | - | - | - | -1,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,439.00 |
| Dec 31, 2025 | -815.00 |
| Sep 30, 2025 | -21,355.00 |
| Jun 30, 2025 | -26,712.00 |
| Mar 31, 2025 | -46,213.00 |
| Dec 31, 2024 | -57,368.00 |
| Sep 30, 2024 | -62,282.00 |
| Jun 30, 2024 | -80,316.00 |
| Mar 31, 2024 | -129,323.00 |
| Dec 31, 2023 | -166,859.00 |
| Sep 30, 2023 | -199,532.00 |
| Jun 30, 2023 | -240,747.00 |
| Dec 31, 2022 | -270,030.00 |
| Sep 30, 2022 | -289,094.00 |
| Dec 31, 2021 | -377,520.00 |
| Sep 30, 2021 | -456,358.00 |
| Jun 30, 2021 | -528,930.00 |
| Mar 31, 2021 | -316,722.00 |
| Dec 31, 2020 | -112,953.00 |
| Sep 30, 2020 | -178,632.00 |